NCT02270918View on ClinicalTrials.gov

Reversibility of Apixaban Anticoagulation With the Four Factor Prothrombin Complex Concentrate Kcentra

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Thrombosis
Interventions
DRUG

Kcentra

IV infusion

DRUG

Apixaban

DRUG

Placebo

Trial Locations (1)

19107

Thomas Jefferson University Hosptial, Philadelphia

Sponsors
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

collaborator

CSL Behring

INDUSTRY

lead

Thomas Jefferson University

OTHER